{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:26:23Z","timestamp":1790695583200,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s40264-017-0584-4","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T10:51:22Z","timestamp":1504003882000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation?"],"prefix":"10.1007","volume":"41","author":[{"given":"Luc M.","family":"Hondeghem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"issue":"263","key":"584_CR1","first-page":"72","volume":"59","author":"Dessertenne F La","year":"1966","unstructured":"La Dessertenne F. tachycardie ventriculaire \u00e0 deux foyers oppos\u00e9s variables. Arch Mal Coeur. 1966;59(263):72.","journal-title":"Arch Mal Coeur."},{"issue":"117","key":"584_CR2","first-page":"22","volume":"45","author":"EW Reynolds","year":"1976","unstructured":"Reynolds EW, Vander Ark CR. Quinidine syncope and the delayed repolarization syndromes. Mod Concepts Cardiovasc Dis. 1976;45(117):22.","journal-title":"Mod Concepts Cardiovasc Dis."},{"issue":"50B","key":"584_CR3","first-page":"2B","volume":"72","author":"DM Roden","year":"1993","unstructured":"Roden DM. Current status of class III antiarrhythmic drug therapy. Am J Cardiol. 1993;72(50B):2B.","journal-title":"Am J Cardiol."},{"issue":"53B","key":"584_CR4","first-page":"4B","volume":"72","author":"RJ Lipicky","year":"1993","unstructured":"Lipicky RJ. A viewpoint on drugs that prolong the QTc interval. Am J Cardiol. 1993;72(53B):4B.","journal-title":"Am J Cardiol."},{"issue":"95","key":"584_CR5","first-page":"100","volume":"13","author":"T Lewis","year":"1926","unstructured":"Lewis T, Drury AN. Revised views of refractory period in relation to drugs reputed to prolong it and in relation to circus movement. Heart. 1926;13(95):100.","journal-title":"Heart."},{"key":"584_CR6","doi-asserted-by":"crossref","unstructured":"Williams EMV. Classification of antiarrhythmic agents. In: Williams EMV, editor. Antiarrhythmic drugs. Handbook of experimental pharmacology series (No. 89). Berlin: Springer-Verlag. 1989. p. 45\u201367.","DOI":"10.1007\/978-3-642-73666-7_2"},{"issue":"758","key":"584_CR7","first-page":"72","volume":"2","author":"RR Shah","year":"2005","unstructured":"Shah RR, Hondeghem LM. Refining detection of drug-induced proarrhythmia: QT interval and TRIaD. Heart Rhythm. 2005;2(758):72.","journal-title":"Heart Rhythm."},{"key":"584_CR8","unstructured":"ICH Topic S 7 B. Step 5. Note for Guidance on the nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals (CPMP\/ICH\/423\/02). 2005. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/general\/general_content_000958.jsp . Accessed 20 Aug 2017."},{"issue":"3","key":"584_CR9","first-page":"10","volume":"121","author":"LM Hondeghem","year":"2016","unstructured":"Hondeghem LM. Disturbances of cardiac wavelength and repolarization precede torsade de pointes and ventricular fibrillation in Langendorff perfused rabbit hearts. Prog Biophys Mol Biol. 2016;121(3):10.","journal-title":"Prog Biophys Mol Biol."},{"issue":"386","key":"584_CR10","first-page":"95","volume":"82","author":"E Ficker","year":"1998","unstructured":"Ficker E, Jarolimek W, Kiehn J, Baumann A, Brown AM. Molecular determinants of dofetilide block of HERG K+ channels. Circ Res. 1998;82(386):95.","journal-title":"Circ Res."},{"issue":"127","key":"584_CR11","first-page":"49","volume":"357","author":"G Isenberg","year":"1984","unstructured":"Isenberg G, Ravens U. The effects of the Anemonia sulcata toxin (ATX II) on membrane currents of isolated mammalian myocytes. J Physiol. 1984;357(127):49.","journal-title":"J Physiol."},{"issue":"367","key":"584_CR12","first-page":"76","volume":"382","author":"LM Hondeghem","year":"2010","unstructured":"Hondeghem LM, Dumotier B, Traebert M. Oscillations of cardiac wave length and proarrhythmia. Naunyn-Schmied Arch Pharmacol. 2010;382(367):76.","journal-title":"Naunyn-Schmied Arch Pharmacol."},{"issue":"103","key":"584_CR13","first-page":"13","volume":"2001","author":"L Hondeghem","year":"2004","unstructured":"Hondeghem L, Carlsson L, Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but APD prolongation is antiarrhythmic. Circulation. 2004;2001(103):13.","journal-title":"Circulation."},{"issue":"14","key":"584_CR14","first-page":"24","volume":"41","author":"LM Hondeghem","year":"2003","unstructured":"Hondeghem LM, Hoffmann P. Blinded test in isolated female rabbit heart reliably identifies action potential duration prolongation and proarrhythmic drugs: importance of triangulation, reverse use dependence, and instability. J Cardiovasc Pharmacol. 2003;41(14):24.","journal-title":"J Cardiovasc Pharmacol."},{"issue":"171","key":"584_CR15","first-page":"81","volume":"49","author":"JP Valentin","year":"2004","unstructured":"Valentin JP, Hoffmann P, De Clerck F, Hammond TG, Hondeghem LM. Review of the predictive value of the Langendorff heart model (SCREENIT system) in assessing the proarrhythmic potential of drugs. J Pharmacol Toxicol. 2004;49(171):81.","journal-title":"J Pharmacol Toxicol."},{"issue":"46","key":"584_CR16","first-page":"59","volume":"52","author":"CL Lawrence","year":"2005","unstructured":"Lawrence CL, Pollard CE, Hammond TG, Valentin JP. Nonclinical proarrhythmia models: predicting torsades de pointes. J Pharmacol Toxicol. 2005;52(46):59.","journal-title":"J Pharmacol Toxicol."},{"issue":"219","key":"584_CR17","first-page":"27","volume":"28","author":"M Viitasalo","year":"2005","unstructured":"Viitasalo M, Paavonen KJ, Swan H, Kontula K, Toivonen L. Effects of epinephrine on right ventricular monophasic action potentials in the LQT1 versus LQT2 form of long QT syndrome: preferential enhancement of \u201ctriangulation\u201d in LQT1. Pacing Clin Electrophysiol. 2005;28(219):27.","journal-title":"Pacing Clin Electrophysiol."},{"issue":"376","key":"584_CR18","first-page":"85","volume":"144","author":"P Champeroux","year":"2005","unstructured":"Champeroux P, Viaud K, El Amrani AI, Fowler JS, Martel E, Le Guennec JY, et al. Prediction of the risk of torsade de pointes using the model of isolated canine Purkinje fibres. Brit J Pharmacol. 2005;144(376):85.","journal-title":"Brit J Pharmacol."},{"issue":"199","key":"584_CR19","first-page":"206","volume":"48","author":"RL Martin","year":"2006","unstructured":"Martin RL, Su Z, Limberis JT, Palmatier JD, Cowart MD, Cox BF, et al. In vitro preclinical cardiac assessment of tolterodine and terodiline: multiple factors predict the clinical experience. J Cardiovasc Pharmacol. 2006;48(199):206.","journal-title":"J Cardiovasc Pharmacol."},{"issue":"196","key":"584_CR20","first-page":"203","volume":"18","author":"D Guo","year":"2007","unstructured":"Guo D, Zhao X, Wu Y, Liu T, Kowey PR, Yan GX. L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation. J Cardiovasc Electrophysiol. 2007;18(196):203.","journal-title":"J Cardiovasc Electrophysiol."},{"issue":"100","key":"584_CR21","first-page":"21","volume":"15","author":"C Antzelevitch","year":"2008","unstructured":"Antzelevitch C. Drug-induced spatial dispersion of repolarization. Cardiol J. 2008;15(100):21.","journal-title":"Cardiol J."},{"issue":"647","key":"584_CR22","first-page":"54","volume":"18","author":"P Milberg","year":"2007","unstructured":"Milberg P, Hilker E, Ramtin S, Cakir Y, Stypmann J, Engelen MA, et al. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes. J Cardiovasc Electrophysiol. 2007;18(647):54.","journal-title":"J Cardiovasc Electrophysiol."},{"issue":"152","key":"584_CR23","first-page":"9","volume":"119","author":"BM Dumotier","year":"2008","unstructured":"Dumotier BM, Deurinck M, Yang Y, Traebert M, Suter W. Relevance of in vitro SCREENIT results for drug-induced QT interval prolongation in vivo: a database review and analysis. Pharmacol Ther. 2008;119(152):9.","journal-title":"Pharmacol Ther."},{"key":"584_CR24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.CIR.81.2.686","volume":"81","author":"LM Hondeghem","year":"1990","unstructured":"Hondeghem LM, Snyders DJ. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Circulation. 1990;81:686\u201390.","journal-title":"Circulation"},{"key":"584_CR25","doi-asserted-by":"crossref","first-page":"H2722","DOI":"10.1152\/ajpheart.00369.2003","volume":"285","author":"YW Qian","year":"2003","unstructured":"Qian YW, Qian YW, Sung RJ, Lin SF, Province R, Clusin WT. Spatial heterogeneity of action potential alternans during global ischemia in the rabbit heart. Am J Physiol Heart Circ Physiol. 2003;285:H2722\u201333.","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"411","key":"584_CR26","first-page":"7","volume":"32","author":"G Tse","year":"2016","unstructured":"Tse G, Wong ST, Tse V, Lee YT, Lin HY, Yeo JM. Cardiac dynamics: alternans and arrhythmogenesis. J Arrhythm. 2016;32(411):7.","journal-title":"J Arrhythm."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-017-0584-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0584-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0584-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T18:04:35Z","timestamp":1570039475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-017-0584-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1007\/s40264-017-0584-4","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,29]]}}}